Investigation of antiparkinsonian activity of new imidazole-4,5-dicarboxylic acid derivatives on the experimental model of catalepsy
Introduction: To study the antiparkinsonian activity of new ligands of the glutamate NMDA receptor complex - 1,2-substituted imidazole-4,5-dicarboxylic acids - on an experimental model of catalepsy caused by haloperidolintraabdominal injections in rats. Materials and methods: The experiments were pe...
Saved in:
Main Authors: | Vladimir D. Dergachev (Author), Ekaterina E. Yakovleva (Author), Maria A. Brusina (Author), Evgeny R. Bychkov (Author), Levon B. Piotrovskiy (Author), Petr D. Shabanov (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression ttests in mice and rats
by: Ekaterina E. Yakovleva, et al.
Published: (2020) -
Experimental pharmacokinetics of a new antiparkinsonian drug ADK-1113
by: O. Yu. Kravtsova, et al.
Published: (2024) -
Possible carcinogenic potential of dimethyl dimethoxy biphenyl dicarboxylate in experimental animals
by: Sanaa Sabet Botros, et al.
Published: (2016) -
Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
by: Sara Silva, et al.
Published: (2021) -
On the Curability of Certain Forms of Insanity, Epilepsy, Catalepsy, and Hysteria in Females
by: Brown, Isaac Baker, 1812-1873